title: Uptake, metabolism, and cytotoxicity of isomeric cholesterol-5,6-epoxides in rabbit aortic endothelial cells.
abstract: The isomeric cholesterol-5,6-epoxides represent two common cholesterol autoxidation products and along with their principal metabolic product, 3 beta,5 alpha,6 beta-cholestane triol, are purportedly angiotoxic. The uptake and cytotoxic action of these compounds was examined in cultured rabbit aortic endothelial cells emphasizing mechanisms of uptake and metabolic fate. The isomeric cholesterol epoxides are incorporated with equal facility and in a dose-dependent manner. The pattern of uptake, which is markedly influenced by media serum concentration and by temperature, suggests that these compounds are partly incorporated through association with serum lipoproteins. After incorporation, both epoxide isomers are rapidly converted to cholestane triol which readily exits the cells. Cholestane triol is further metabolized to an ester-type product representing up to 10% of the added cholesterol epoxides by 24 h of incubation. The order of cytotoxic potency of these cholesterol oxides is: cholestane triol greater than cholesterol-beta-epoxide greater than cholesterol-alpha-epoxide, with LD50 concentrations ranging from 23 to greater than 150 microM in confluent cells. Cholestane triol and cholesterol-beta-epoxide are twice as cytotoxic to subconfluent cells as compared to confluent cells, whereas cholesterol-alpha-epoxide is essentially equitoxic to confluent and subconfluent cells. Cholesterol epoxide cytotoxicity is significantly reduced by treatments in the absence of serum in accord with substantial reduction in uptake when incubations are performed in serum-free media. Our findings show that these cytotoxic cholesterol oxides are incorporated by endothelial cells through a combination of receptor-mediated and nonspecific or passive mechanisms; however, the efficacy of uptake and resulting toxicity is substantially influenced by serum lipoproteins.
authors.affiliation: Institute for Toxicology, University of Southern California, Los Angeles 90033.
authors.forename: A
authors.initials: A
authors.lastname: Sevanian
authors.forename: J
authors.initials: J
authors.lastname: Berliner
authors.forename: H
authors.initials: H
authors.lastname: Peterson
mesh_terms: D000818:Animals; D001011:Aorta; D002470:Cell Survival; D002478:Cells, Cultured; D002777:Cholestanols / Q000378:metabolism / Q000633:toxicity; D002784:Cholesterol / Q000031:analogs & derivatives* / Q000378:metabolism / Q000633:toxicity; D004730:Endothelium, Vascular / Q000166:cytology / Q000378:metabolism*; D000960:Hypolipidemic Agents; D007536:Isomerism; D007700:Kinetics; D011817:Rabbits; D013696:Temperature; D014461:Ultracentrifugation
chemical_list: D002777:Cholestanols; D000960:Hypolipidemic Agents; C000474:cholestane-3,5,6-triol; C002415:cholesterol alpha-oxide; D002784:Cholesterol